Episode 017 | Andy Bolan (Associate Director of Patient and Medical Community Engagement at ProQR Therapeutics) joins the podcast. Based in the Netherlands, ProQR is a biotechnology company dedicated to changing lives by developing RNA therapies for rare genetic diseases. More specifically, they focus their drug development mainly on a group of blinding disorders affecting the retina, called inherited retinal diseases. We discuss the science happening in their labs and how important genetic testing is for people with an inherited retinal disease. | To learn more about ProQR Therapeutics, visit: https://www.proqr.com | Andy's featured organization was Retina International. To learn more, visit: retina-international.org | To learn more about the podcast, visit: seethroughpod.com